$EHTH

eHealth (EHTH) SVP Galimi reports 3,588-share tax withholding on Form 4

eHealth, Inc.'s Senior Vice President and General Counsel, Gavin G. Galimi, reported a tax-related disposition of 3,588 shares of common stock. These shares, valued at $1.89 each, were withheld to satisfy a tax withholding obligation associated with equity compensation, rather than being sold in the open market. Following this transaction, Galimi directly owns 277,158 shares of eHealth common stock.

Original reporting
Published Apr 28, 2026, 8:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 28, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
eHealth (EHTH) SVP Galimi reports 3,588-share tax withholding on Form 4 — source image
Decision brief

The 30-second read

$EHTHNeutralLow
01

Why it matters

Since the shares were withheld for tax purposes and not sold, this action does not indicate a change in insider sentiment or a signal to the market.

02

Market read

The insider activity is routine and primarily tax-driven, with minimal impact on market perception or stock price.

03

What to watch

The transaction does not involve a sale or transfer of ownership, and may simply reflect routine tax obligations rather than strategic insider trading.

Timing: low

Background

Gavin G. Galimi, SVP and General Counsel of eHealth, reported a tax-related share withholding of 3,588 shares, valued at approximately $6,781, based on the share price of $1.89.

Company-level read

Ticker impact

$EHTHNeutralMedium confidence
Context

The insider transaction involves a senior executive of eHealth, Inc., indicating potential insider sentiment but limited immediate market impact.

Expected impact

Minimal to no immediate impact on stock price; potential slight negative bias if viewed as insider cashing out, but since shares were withheld for tax purposes, the effect is likely negligible.

Evidence & confidence

The transaction is related to tax withholding, a common corporate action, and does not necessarily reflect the company's fundamentals or future prospects.

Market effects

Limited sector impact; insider transactions are company-specific and do not significantly influence the broader finance or healthcare sectors.

None expected; the transaction is localized to the company's insider activity.

Negligible; no direct global market implications.

Counterpoint

Some traders might interpret insider withholding of shares as a lack of confidence, but in this context, it is primarily a tax-related action.

Key entities

  • Gavin G. Galimi

    Senior Vice President and General Counsel of eHealth, Inc.

  • eHealth, Inc.

    A provider of health insurance services and related technology.

Related articles

$EHTHMed

eHealth, Inc. (EHTH): Results of Operations and Financial Condition

eHealth, Inc. (EHTH) filed an SEC Form 8-K — Results of Operations and Financial Condition. eHealth, Inc. Announces Second Quarter 2026 Results Lifetime Advisory Model increasing member engagement On track to achieve meaningful YoY improvements in annual operating cash flow INDIANAPOLIS — August 4, 2026 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health ins

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.

$BKRMed

Baker Hughes (BKR) Lands Multi-Year Contract with Pakistan’s OGDC

Baker Hughes (BKR) secured a multi-year contract with Pakistan's OGDC to enhance production from mature oil and gas fields. The deal involves assessing 120 wells and providing tailored redevelopment plans. Baker Hughes aims to use AI and other technologies to improve flow assurance and restore production. The contract aligns with Baker Hughes' strategy to diversify revenue and reduce reliance on short-term drilling cycles, as evidenced by a 49% YoY increase in orders to $10.5 billion in Q2. Howe

$AAPLMed

Tim Cook Delivered a 2,720% Total Return Over 15 Years. Here's Whether John Ternus Can Do the Same for Apple Investors.

Tim Cook stepped down as Apple CEO after 15 years, delivering 2,720% total returns. New CEO John Ternus faces challenges, including margin pressure from rising memory costs. Apple is set to launch new iPhone models this week. iPhone sales grew over 20% in recent quarters, but management expects slower growth. Apple stock fell on margin concerns despite briefly surpassing $5 trillion.